Altered Myeloid Development and Acute Leukemia in Transgenic Mice Expressing PML-RARα Under Control of Cathepsin G Regulatory Sequences

作者: Jay L. Grisolano , Robin L. Wesselschmidt , Pier Giuseppe Pelicci , Timothy J. Ley

DOI: 10.1182/BLOOD.V89.2.376

关键词: MyeloidAcute leukemiaRUNX1T1Cancer researchMyeloid leukemiaRetinoic acid receptor alphaBiologyLeukemiaAcute promyelocytic leukemiaPromyelocytic leukemia protein

摘要: Acute promyelocytic leukemia (APML) is characterized by abnormal myeloid development, resulting an accumulation of leukemic promyelocytes that are often highly sensitive to retinoic acid. A balanced t(15;17) (q22;q21) reciprocal chromosomal translocation found in approximately 90% APML patients; this fuses the PML gene on chromosome 15 acid receptor alpha (RAR alpha) 17, creating two novel fusion genes, PML-RAR and RAR alpha-PML. The product, which expressed virtually all patients with t(15;17), thought play a direct role pathogenesis APML. To determine whether sufficient cause animal model, we used promyelocyte-specific targeting sequences human cathepsin G (hCG) expression cDNA early cells transgenic mice. Mice expressing hCG-PML-RAR transgene were have altered development was increased percentages immature mature peripheral blood, bone marrow, spleen. In addition, 30% transgene-expressing mice eventually developed acute after long latent period. splenic both nonleukemic phenotypes responded all-trans (ATRA) treatment, caused apoptosis precursors. Although low-level not directly mice, its alters precursors may be susceptible cooperative transforming events.

参考文章(53)
M.H. Koken, F. Puvion-Dutilleul, M.C. Guillemin, A. Viron, G. Linares-Cruz, N. Stuurman, L. de Jong, C. Szostecki, F. Calvo, C. Chomienne, The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion The EMBO Journal. ,vol. 13, pp. 1073- 1083 ,(1994) , 10.1002/J.1460-2075.1994.TB06356.X
M Lafage-Pochitaloff, M Alcalay, V Brunel, L Longo, D Sainty, J Simonetti, F Birg, PG Pelicci, Acute promyelocytic leukemia cases with nonreciprocal PML/RARa or RARa/PML fusion genes Blood. ,vol. 85, pp. 1169- 1174 ,(1995) , 10.1182/BLOOD.V85.5.1169.1169
MT Daniel, M Koken, O Romagne, S Barbey, A Bazarbachi, M Stadler, MC Guillemin, L Degos, C Chomienne, H de The, PML protein expression in hematopoietic and acute promyelocytic leukemia cells Blood. ,vol. 82, pp. 1858- 1867 ,(1993) , 10.1182/BLOOD.V82.6.1858.1858
S Dziennis, RA Van Etten, HL Pahl, DL Morris, TL Rothstein, CM Blosch, RM Perlmutter, DG Tenen, The CD11b promoter directs high-level expression of reporter genes in macrophages in transgenic mice [published erratum appears in Blood 1995 Apr 1;85(7):1983] Blood. ,vol. 85, pp. 319- 329 ,(1995) , 10.1182/BLOOD.V85.2.319.BLOODJOURNAL852319
A. Perez, P. Kastner, S. Sethi, Y. Lutz, C. Reibel, P. Chambon, PMLRAR homodimers: Distinct DNA binding properties and heteromeric interactions with RXR The EMBO Journal. ,vol. 12, pp. 3171- 3182 ,(1993) , 10.1002/J.1460-2075.1993.TB05986.X
M. H. M. Koken, F. Quignon, G. Linares-Cruz, F. Calvo, L. Juhlin, J. Sobczak-Thepot, M. K. Chelbi-Alix, L. Degos, A. Viron, The PML growth-suppressor has an altered expression in human oncogenesis. Oncogene. ,vol. 10, pp. 1315- 1324 ,(1995)
M. G. Paggi, A. Felsani, A. Floridi, G. Santarelli, F. Bonetto, P. De Fabritiis, A. Spadea, L. Amadio, F. P. Gentile, The Retinoblastoma Gene Product in Acute Myeloid Leukemia: A Possible Involvement in Promyelocytic Leukemia Cancer Research. ,vol. 55, pp. 4552- 4556 ,(1995)